Skip to main content

Month: December 2020

Eloro Resources Announces C$3 Million Bought Deal Financing

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES.TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (the “Company” or “Eloro”) (TSX-V: ELO; OTCQX: ELRRF; FSE: P2QM) is pleased to announce that it has entered into an agreement with Haywood Securities Inc. (“Haywood”) to act as lead underwriter and sole bookrunner, on behalf of a syndicate of underwriters including Echelon Wealth Partners Inc. (together with Haywood, the “Underwriters”) pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 1,936,000 units (the “Units”) at a price of C$1.55 per Unit (the “Issue Price”) for gross proceeds to the Company of C$3,000,800 (the “Offering”).Each Unit will consist of one...

Continue reading

ISW Holdings Eliminates $702K of Debt in Deal with Major Noteholders

LAS VEGAS, NV, Dec. 09, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company, is pleased to announce that the Company and its largest noteholders have reached an agreement (the “Agreement”) whereby about 50% of the current convertible debt owed by the Company will be exchanged for restricted preferred equity, eliminating a significant portion of the dilution potential from convertible debentures now carried in the Company’s books.Specifically, the Company and its largest noteholder have agreed to exchange convertible debentures (principal and interest) with an aggregate value of $602K for restricted Preferred B equity, thereby reducing total debt and significantly curtailing dilution potential over the coming months and years.“The...

Continue reading

OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics

Dr. Arne Materna to join Ares Genetics as new Managing Director and CEO to lead Ares into next phase of its growth Dr. Andreas Posch, while stepping down as Managing Director and CEO to pursue new opportunities, remains on board throughout 2021 as special advisor to facilitate smooth transitionGAITHERSBURG, Md. and VIENNA, Austria, Dec. 09, 2020 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), announced today a planned transition in the leadership of its wholly owned subsidiary Ares Genetics GmbH (Vienna, Austria; “Ares Genetics”). Dr. Andreas Posch, founding CEO of Ares Genetics, has decided to step down as Managing Director and CEO of Ares Genetics at his own request, effective December 31, 2020. As part of the transition planning following the successful business combination with OpGen, Dr. Achim Plum will also step down...

Continue reading

Pacira BioSciences Reports Preliminary Net Product Sales of $38.9 Million for November 2020

— EXPAREL average daily sales at 103% of the prior year for the month of November 2020 —PARSIPPANY, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the leading provider of innovative non-opioid pain management options, today reported preliminary unaudited net product sales of EXPAREL® (bupivacaine liposome injectable suspension) and iovera° of $38.1 million and $0.8 million, respectively, for the month of November 2020.“We are pleased to report our sixth consecutive month of year-over-year growth for EXPAREL in the face of ongoing challenges from the COVID-19 pandemic. Sales for the final two days of November were meaningfully below the daily average for the month, which we believe to be attributable to the Thanksgiving holiday. Such anomalies aside, market indicators remain favorable...

Continue reading

Kelly® Professional & Industrial Business Unit Executive Announces Retirement; Ushers in Successor

TROY, Mich., Dec. 09, 2020 (GLOBE NEWSWIRE) — After a successful 20-year career in the staffing industry – the last 13 years spent with Kelly – Deb Thorpe will be retiring in January 2021 from her role as president of Kelly’s Professional & Industrial (P&I) business unit. A respected industry veteran, Thorpe’s deep operational expertise and positive leadership style earned her a reputation as a problem-solver who rallied teams to achieve results in the face of change. “I’ve worked with Deb for 13 years and have never seen her back down from a professional challenge,” said Kelly President and CEO Peter Quigley. “Her passion for Kelly’s mission and her unshakeable faith in people has been the driving force behind her long and successful career, and we’ve all benefited from her leadership.”Thorpe’s career spanned numerous...

Continue reading

Century Fire Protection Broadens Geographic Footprint

TORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — FirstService Corporation (TSX and NASDAQ: FSV) (“FirstService”) announced today that its subsidiary, Century Fire Protection (“Century”), has recently acquired Aegis Fire Protection, LLC (“Aegis”) and Cornet, Inc. (“Cornet”). The leaders of both businesses have retained minority equity interests and will continue to run day-to-day operations. Terms of the transactions were not disclosed.Aegis and Cornet are both full-service fire protection companies specializing in the installation, service and inspection of fire sprinkler, alarm and suppression systems. Founded in 2007 and headquartered in Kansas City, Aegis is a market-leading player in the Kansas City metropolitan area and surrounding regions within the states of Kansas and Missouri. Cornet, established in 2005 and based in Chantilly,...

Continue reading

Cytokinetics Announces Progression of REDWOOD-HCM to Cohort 2

SOUTH SAN FRANCISCO, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the progression of REDWOOD-HCM following the conduct of an interim analysis of data from Cohort 1. REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM) is an ongoing Phase 2 clinical trial of CK-3773274 (CK-274), a next-generation cardiac myosin inhibitor in development for the potential treatment of hypertrophic cardiomyopathy (HCM).The interim analysis of data from Cohort 1 of REDWOOD-HCM showed patients experienced substantial reductions in the average resting left ventricular outflow tract gradient (LVOT-G) as well as the post-Valsalva LVOT-G (defined as resting gradient 30 mmHg or post-Valsalva LVOT-G >50 mmHg), the patient was up-titrated to receive 10 mg (or placebo)...

Continue reading

Compass Gold to Further Increase Private Placement to Raise Up to $3.7 Million

Not for distribution to United States newswire services or for dissemination in the United StatesTORONTO, Dec. 09, 2020 (GLOBE NEWSWIRE) — Compass Gold Corp. (TSX-V: CVB) (“Compass” or the “Company”) announced today that, as a result of substantial investor demand, it has further increased the size of its initially announced $2.5 million private placement (the “Offering”) (see Compass news releases dated November 30 and December 7, 2020) and will now issue up to 18,500,000 common shares of the Company, at $0.20 per share, for aggregate gross proceeds of up to $3.7 million.The proceeds from this offering will be used to fund exploration, including a 17,000-meter drill program to be completed before the end of Q2, 2021, and for general corporate purposes. Drilling will focus on mineralized trends on the Tarabala and Samagouela targets...

Continue reading

Orion Secures Approx. $40M Contract Extension Expanding Turnkey LED Lighting & Controls Retrofit Project for Major National Retail Customer

MANITOWOC, Wis., Dec. 09, 2020 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), is a provider of LED lighting systems and turnkey project implementation, including installation and commissioning of fixtures, controls and IoT capabilities, ongoing system maintenance and program management. Orion today announced it has secured a new contract extension totaling approximately $40 million for the turnkey LED lighting and controls retrofit of 290 additional locations for an existing large national retail customer.Orion currently expects to recognize product and service revenue from the additional locations starting in the fourth quarter of Fiscal 2021 through the third quarter of Fiscal 2022. This estimated timing is subject to uncertainty related to the COVID-19 pandemic and related business and other economic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.